SUBSCRIBE
SUBSCRIBE

Codiak BioSciences

NEWS
Codiak Biosciences filed for bankruptcy in 2023.
Business
Codiak Receives $72.5 Million Up Front from Sarepta in Neuromuscular Disease Research Pact
Sarepta Therapeutics entered into a research alliance with Codiak BioSciences to design and develop engineered exosome therapeutics for neuromuscular diseases.
June 22, 2020
 · 
3 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: June 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 1, 2020.
May 28, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Deals
Codiak Biosciences Lines up for $86 Million IPO
The company is banking on investors approving of its approach to harness exosomes, which had once been considered the cells’ garbage cans, as a means of pioneering a new class of biologic medicines.
May 1, 2019
 · 
2 min read
 · 
Alex Keown
Deals
BioSpace’s List of April 2019 Life Science IPOs
A summary of IPOs from companies in the biotech and pharma world since April 1, 2019.
April 5, 2019
 · 
2 min read
 · 
Editorial Staff
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Former Biogen Exec’s Startup Codiak BioSciences Bags Another $61 Million, Totaling $92 Million for Exosome Research
January 26, 2016
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Business
Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational Progress
August 4, 2022
 · 
9 min read
Genetown
Codiak BioSciences to Participate in Upcoming BTIG and Wedbush PacGrow Investor Conferences
August 3, 2022
 · 
1 min read
Genetown
Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022
July 11, 2022
 · 
2 min read
Business
CEPI and Codiak BioSciences partner to develop broadly protective Betacoronavirus vaccine
July 5, 2022
 · 
7 min read
Drug Development
Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials of exoSTING™ and exoIL-12™
June 30, 2022
 · 
11 min read
Drug Development
Codiak Initiates Patient Dosing in Phase 1 Clinical Trial of exoASO™-STAT6 in Patients with Advanced Hepatocellular Carcinoma, Liver Metastases from Primary Gastric Cancer and Colorectal Cancer
June 29, 2022
 · 
5 min read
Drug Development
Codiak Presents New Preclinical Data at ASGCT 2022 on Exosome-Based Strategy to Enhance AAV Gene Therapy
May 17, 2022
 · 
5 min read
Business
Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational Progress
May 5, 2022
 · 
8 min read
Business
Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
May 2, 2022
 · 
5 min read
Drug Development
Codiak Presents New Preclinical Data Supporting Development of a Broadly Protective Pan Beta-Coronavirus Vaccine
April 20, 2022
 · 
6 min read
Load More